ONCTERNAL THERAPEUTICS INC's ticker is ONCT and the CUSIP is 68236P107. A total of 60 filers reported holding ONCTERNAL THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $43,330 | -13.0% | 144,434 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $49,830 | -56.1% | 144,434 | 0.0% | 0.00% | -66.7% |
| Q1 2023 | $113,381 | -21.5% | 144,434 | 0.0% | 0.00% | -25.0% |
| Q4 2022 | $144,434 | +12.0% | 144,434 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $129,000 | -19.4% | 144,434 | 0.0% | 0.00% | -20.0% |
| Q2 2022 | $160,000 | -20.4% | 144,434 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $201,000 | +22.6% | 144,434 | +100.0% | 0.01% | +25.0% |
| Q4 2021 | $164,000 | -45.5% | 72,217 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $301,000 | -12.2% | 72,217 | 0.0% | 0.01% | -20.0% |
| Q2 2021 | $343,000 | -42.9% | 72,217 | 0.0% | 0.01% | -60.0% |
| Q1 2021 | $601,000 | +69.8% | 72,217 | 0.0% | 0.02% | +56.2% |
| Q4 2020 | $354,000 | +187.8% | 72,217 | 0.0% | 0.02% | +128.6% |
| Q3 2020 | $123,000 | -40.0% | 72,217 | 0.0% | 0.01% | -46.2% |
| Q2 2020 | $205,000 | -3.3% | 72,217 | 0.0% | 0.01% | -23.5% |
| Q1 2020 | $212,000 | – | 72,217 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,256,717 | $3,569,000 | 0.16% |
| DOWLING & YAHNKE LLC | 150,464 | $427,000 | 0.04% |
| Aureus Asset Management, LLC | 70,211 | $199,000 | 0.02% |
| IEQ CAPITAL, LLC | 72,217 | $205,000 | 0.01% |
| Cohen Capital Management, Inc. | 13,046 | $37,000 | 0.01% |
| Creative Planning | 487,737 | $1,385,000 | 0.00% |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | 84,605 | $240,000 | 0.00% |
| North Star Investment Management Corp. | 4,000 | $11,000 | 0.00% |
| DELTA ASSET MANAGEMENT LLC/TN | 7 | $0 | 0.00% |
| MORGAN STANLEY | 21,342 | $61,000 | 0.00% |